Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics This study covers the world outlook for melanoma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs This study covers the world outlook for anaplastic thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs This study covers the world outlook for breast cancer diagnostic and drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Cancer Registry Software
The 2025-2030 World Outlook for Cancer Registry Software This study covers the world outlook for cancer registry software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Specialty Hospitals
The 2025-2030 World Outlook for Cancer Specialty Hospitals This study covers the world outlook for cancer specialty hospitals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Hemato Oncology Testing
The 2025-2030 World Outlook for Hemato Oncology Testing This study covers the world outlook for hemato oncology testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics This study covers the world outlook for hormone-drug breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Targeted Therapy Kidney Cancer Drugs
The 2025-2030 World Outlook for Targeted Therapy Kidney Cancer Drugs This study covers the world outlook for targeted therapy kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics This study covers the world outlook for oncology based molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma
The 2025-2030 World Outlook for Multiple Myeloma This study covers the world outlook for multiple myeloma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics This study covers the world outlook for acute lymphocytic-lymphoblastic leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Diagnostics
The 2025-2030 World Outlook for Lung Cancer Diagnostics This study covers the world outlook for lung cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors This study covers the world outlook for immuno-oncology immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Non-Hematological Cancers
The 2025-2030 World Outlook for Non-Hematological Cancers This study covers the world outlook for non-hematological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments This study covers the world outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics This study covers the world outlook for non-Hodgkin lymphoma chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies
The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies This study covers the world outlook for oncolytic virotherapy cancer gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Lymphoma Therapeutics
The 2025-2030 World Outlook for Lymphoma Therapeutics This study covers the world outlook for lymphoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma
The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma This study covers the world outlook for premetrexed and combinations for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for External Beam Radiation Oncology Therapies
The 2025-2030 World Outlook for External Beam Radiation Oncology Therapies This study covers the world outlook for external beam radiation oncology therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Therapeutics
The 2025-2030 World Outlook for Liver Cancer Therapeutics This study covers the world outlook for liver cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products This study covers the world outlook for breast cancer diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics
The 2025-2030 World Outlook for Breast Cancer Diagnostics This study covers the world outlook for breast cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Therapeutics
The 2025-2030 World Outlook for Breast Cancer Therapeutics This study covers the world outlook for breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
Research Assistance
